Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Johnson and Johnson
Mallinckrodt
McKesson
Express Scripts

Last Updated: June 28, 2022

Investigational Drug Information for AFQ056


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug AFQ056?

AFQ056 is an investigational drug.

There have been 25 clinical trials for AFQ056. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2011.

The most common disease conditions in clinical trials are Parkinson Disease, Dyskinesias, and Syndrome. The leading clinical trial sponsors are Novartis Pharmaceuticals, Novartis, and Yale University.

Recent Clinical Trials for AFQ056
TitleSponsorPhase
Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor MavoglurantYale UniversityEarly Phase 1
Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056National Institute on Drug Abuse (NIDA)Phase 1
Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056Novartis PharmaceuticalsPhase 1

See all AFQ056 clinical trials

Clinical Trial Summary for AFQ056

Top disease conditions for AFQ056
Top clinical trial sponsors for AFQ056

See all AFQ056 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
Johnson and Johnson
Mallinckrodt
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.